Long non-coding RNAs (lncRNAs) are non-coding transcripts that have emerged as one of
the largest and diverse RNA families that regulate gene expression. Accumulating evidence …

Diabetes is one of the most frequently occurring metabolic disorders, affecting almost one
tenth of the global population. Despite advances in antihyperglycemic therapeutics, the …

Background: Type 2 diabetes mellitus (T2DM) is the most common metabolic disorder. The
aim of the present investigation was to identify gene signature specific to T2DM. Methods …

Background This study aimed to investigate the involvement of lncRNA CTBP1-AS2 in the
progression of diabetic nephropathy (DN) by affecting high glucose (HG)-induced human …

Periodontitis is a significant health concern for individuals with diabetes mellitus (DM),
characterized by inflammation and periodontium loss. Hyperglycaemia in DM exacerbates …

Background: Colorectal cancer (CRC), the most commonly diagnosed cancer in the world,
has a high mortality rate. In recent decades, long non-coding RNAs (lncRNAs) have been …

Type 2 diabetes mellitus (T2DM) is a worldwide disease with rapidly increasing prevalence.
This complex disorder caused by interplay between genetic predisposition factors, early …

This article reviews recent advances in the study of microRNAs (miRNAs), long non-coding
RNAs (lncRNAs), and their functions in type 2 diabetes mellitus (T2DM), ischemic stroke (IS) …

Abstract Objectives LncRNA CTBP1-AS2 has been reported to be involved in type 2
diabetes and cardiomyocyte hypertrophy, while its roles in other human diseases are …

The discovery of non-coding RNAs (ncRNAs) has opened a new paradigm to use ncRNAs
as biomarkers to detect disease progression. Long non-coding RNAs (lncRNA) have …